This review synthesizes available evidence indicating that several KIFs, specifically KIF4A, KIF14, KIF20A, and KIFC1, function as key oncogenic regulators and represent important prognostic biomarkers and therapeutic targets in bladder cancer.
Usamah Sayed, Noor Mazin Basheer, M. H. et al.· Cell Biology International· 0 citations
This review synthesizes recent nanomedicine strategies that aim to bridge the gap between biomarker-oriented nanosensors and imaging probes for earlier detection with targeted nanocarriers designed to overcome delivery barriers, particularly the blood–brain barrier, while improving pharmacokinetics and limiting off-target exposure.
M. Ardah, Baraa Mohammed Yaseen, H. Malathi et al.· Discover Nano· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.